| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
phenotype | 0.400 | None | 1.000 | 15 | 0 | 1997 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.330 | None | 1.000 | 3 | 0 | 1991 | 2018 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
phenotype | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
phenotype | 0.200 | None | 0.842 | 17 | 1 | 2006 | 2017 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.150 | None | 1.000 | 5 | 0 | 1996 | 2017 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.130 | None | 1.000 | 3 | 0 | 1990 | 2017 | ||||||||
|
integrin subunit beta 2 | 0.444 | 0.923 | 5.1E-15 |
|
phenotype | 0.120 | None | 1.000 | 2 | 0 | 2001 | 2001 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Rac family small GTPase 2 | 0.556 | 0.731 | 0.97 |
|
phenotype | 0.110 | None | 1.000 | 1 | 1 | 2002 | 2002 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 34 | 0 | 2011 | 2020 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
phenotype | 0.100 | None | 0.929 | 14 | 0 | 1993 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1993 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2016 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2015 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.030 | None | 1.000 | 2 | 0 | 1991 | 2011 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
leucyl and cystinyl aminopeptidase | 0.514 | 0.731 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1993 | 2011 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 |